[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"rhabdomyolysis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:rhabdomyolysis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,45,76,106,146],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100633562","effect-of-battlefield-acupuncture-on-pain-control-during-inpatient-treatment-of-exertional-rhabdomyolysis-100633562",false,"NCT07528300","Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis","Inclusion Criteria:\n\n* Rhabdomyolysis\n* chooses battlefield acupuncture\n\nExclusion Criteria:\n\n* Greater than 72 hours from onset of symptoms\n* younger than 18 years of age\n* declines battlefield acupuncture\n* no pain",true,"ALL","18 Years","99 Years",{"count":20,"type":21},36,"ESTIMATED","INTERVENTIONAL",[24],"NA","Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.",[27],"Rhabdomyolysis",[29,30,31],"battlefield acupuncture","rhabdomyolysis","pain management","RECRUITING","2026-04-09",{"date":35,"type":36},"2026-04-14","ACTUAL",{"date":38,"type":36},"2023-04-24",{"date":40,"type":21},"2028-04-24",{"name":42,"class":43},"Tripler Army Medical Center","FED",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":60,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":44},"100620762","evaluation-of-the-effectiveness-of-using-virtual-reality-glasses-in-prehospital-intervention-training-for-crush-syndrome-100620762","NCT07361835","Evaluation of the Effectiveness of Using Virtual Reality Glasses in Prehospital Intervention Training for Crush Syndrome","Inclusion Criteria:\n\nBeing a second-year student currently enrolled in the first and emergency aid program at Muğla Sıtkı Koçman University.\n\nVoluntarily providing written informed consent to participate in the study. Having basic technological literacy to use virtual reality equipment.\n\nExclusion Criteria:\n\nFirst-year students who have not yet reached the relevant stage of the curriculum.\n\nStudents who have previously participated in a similar virtual reality-based crush syndrome simulation.\n\nStudents with medical conditions that may be aggravated by VR use (e.g., severe motion sickness, history of seizures).\n\nRefusal to participate voluntarily.",{"count":52,"type":21},61,[24],"This research is a randomized controlled study designed to develop and evaluate the effectiveness of a video-based virtual reality (VR) simulation for prehospital intervention training of crush syndrome for paramedic students. The study aims to examine the impact of VR simulation on knowledge levels, satisfaction, and sense of presence among second-year first and emergency aid students at Muğla Sıtkı Koçman University.",[27,56,57,58,59],"Virtual Reality","Emergency Medical Services","Disaster Medicine","Crush Injuries",[61,62,63,64],"Prehospital Care","Paramedics","Simulation Training","Virtual Reality Simulation","NOT_YET_RECRUITING","2026-01-21",{"date":68,"type":36},"2026-01-23",{"date":70,"type":21},"2026-02",{"date":72,"type":21},"2026-05",{"name":74,"class":75},"Ege University","OTHER",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":84,"maxAge":4,"enrollmentInfo":85,"targetDuration":4,"studyType":87,"phases":4,"briefSummary":88,"conditions":89,"keywords":94,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":44},"100605133","the-rhabdomyolysis-evaluation-in-the-emergency-department-reed-score-100605133","NCT07158554","The Rhabdomyolysis Evaluation in the Emergency Department (REED) Score","The Rhabdomyolysis Evaluation in the Emergency Department (REED) Score - a Risk Prediction Model for Older Adults in the Emergency Department With Rhabdomyolysis After Prolonged Immobilisation (\"Long Lie\")","The REED Score","Inclusion Criteria:\n\nThe participants need to fulfil all three parts of the inclusion criteria:\n\n1. 60 years old or older at time of ED presentation\n2. Developed rhabdomyolysis (defined as CK \\>999U\u002FL)\n3. Have had a fall and been \u002F suspected to have been on the floor \u002F immobilised in one position for \\> 59 minutes.\n\nExclusion Criteria:\n\n1. Patient opted out of research studies via the National Data Opt Out (NDOO) Service.\n2. Principal Investigator (PI) had clinical input into patient care.\n3. Other causes of elevated creatine kinase (e.g. seizures, acute coronary syndromes, burns, myositis, muscular dystrophy, cardiac arrest)","60 Years",{"count":86,"type":21},1000,"OBSERVATIONAL","One in three adults over 65 fall annually, with one in five remaining on the floor for greater than one hour, which is referred to as a long lie. Pressure on the National Health Service has resulted in extended stays in the Emergency Department (ED) (sometimes longer than 12 hours) and prolonged ambulance response times. This impacts the older adults who have fallen and remain on the floor.\n\nThis project aims to develop a risk prediction model (RPM) for use within the ED to understand which older adults (60 years or older) who fall over and remain on the floor for longer than one hour (\"long lie\") and develop rhabdomyolysis (a serious condition where muscle breaks down and releases substances into the blood that can damage the kidneys) will develop poor outcomes and need admission to hospital for treatment and which patients can be safely discharged home.\n\nAim:\n\nTo develop a RPM to identify which older adults who have a fall and a long lie and attend the ED develop poor outcomes such as Acute kidney Injury (AKI) \\[kidneys suddenly stop working properly\\], needing kidney replacement therapy (KRT) \\[a treatment that helps kidneys that aren't working properly do their job of cleaning the blood\\] and mortality \\[death\\].\n\nObjectives:\n\n1. Abstract patient level data (e.g. biochemical, demographic, situational, medical history, medication history) from medical records combined with outcomes to understand which variables lead to poor outcomes such as AKI, needing KRT and mortality.\n2. Analyse the data using a statistical package (Statistical Package for Social Sciences \\[SPSS\\]) to develop a RPM with good discriminative abilities \\[how well the score can tell high-risk from low-risk patients\\].\n3. Demonstrate the ability of the RPM to identify which patients need admission to hospital with treatment and which patients can be safely discharged home.",[27,90,91,92,93],"Death","Kidney Replacement Therapy","Fall Patients","Acute Kidney Injury",[82,27,95,96],"Emergency Department","Long Lie","2025-09-10",{"date":99,"type":36},"2025-09-17",{"date":101,"type":21},"2025-10",{"date":103,"type":21},"2026-04",{"name":105,"class":75},"University of Salford",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":114,"targetDuration":116,"studyType":87,"phases":4,"briefSummary":117,"conditions":118,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":145},"100450503","cytosorb-treatment-of-critically-ill-patients-registry-100450503","NCT05146336","CytOSorb TreatMent Of Critically Ill PatientS Registry","CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting","COSMOS","Inclusion Criteria:\n\n1. Planned OR actual CytoSorb® 300 mL device utilization\n2. Informed consent for prospective registry participation\n\nExclusion Criteria:\n\n1. Use of the CytoSorb® 300 mL device for antithrombotic removal only\n2. Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only\n3. The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate.",{"count":115,"type":21},3000,"3 Months","Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care",[119,120,121,27,122,123,124,125,126,127,128,129,130,131,132,133,134,135],"Septic Shock","Acute Respiratory Distress Syndrome","Trauma","Cardiogenic Shock","Pancreatitis","Acute on Chronic Liver Failure","Acute Liver Failure","Burns","Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)","Extracorporeal Life Support","Postoperative Endocarditis","Hemophagocytic Lymphohistiocytoses","Liver Transplant; Complications","Infectious Disease","Postoperative Vasoplegic Syndrome","Drug Overdose","Sepsis",{"date":137,"type":36},"2025-09-11",{"date":139,"type":36},"2022-06-22",{"date":141,"type":21},"2032-09",{"name":143,"class":144},"CytoSorbents, Inc","INDUSTRY",28,{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":11,"sex":16,"minAge":153,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":22,"phases":157,"briefSummary":159,"conditions":160,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":44},"100549128","phase-1-dexamethasone-use-in-pediatric-rhabdomyolysis-patients-in-addition-to-standard-protocols-100549128","NCT06429982","Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols","A Clinical Trial to Assess Whether Dexamethasone Addition to Standard Protocols for Non-Traumatic Rhabdomyolysis of Unknown or Genetic Etiologies Improves Patient Outcomes","Inclusion Criteria\n\n1. Diagnosis of rhabdomyolysis defined as creatine kinase\\> 5000 with trauma excluded\n2. Ability of parents\u002Fpatients to understand and the willingness to sign a written informed consent document.\n3. Patients ages 12 and older will sign written assent\n\nExclusion Criteria:\n\n* Already taking systemic steroids.\n* Inability to comply with study instructions.\n* Uncontrolled intercurrent illness or psychiatric illness\u002Fsocial situations that would limit compliance with study requirements.\n* Pregnant women.\n\n  o A urine pregnancy test will be performed for women of child-bearing potential.\n* Below gestational age of 40 weeks\n* Allergy to fluconazole, clotrimazole or nystatin.\n* Cannot tolerate PO medications","6 Months","25 Years",{"count":156,"type":21},50,[158],"PHASE1","There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to standard care guidelines.\n\nThe hypothesis is that patients who receive dexamethasone in addition to standard care versus placebo and standard care will have improvement in pain, length of hospital stay, and decrease in kidney complications.",[27],"2025-07-01",{"date":163,"type":36},"2025-07-03",{"date":165,"type":36},"2024-10-01",{"date":167,"type":21},"2026-12-31",{"name":169,"class":75},"Children's National Research Institute"]